ClinConnect ClinConnect Logo
Search / Trial NCT00352989

Effectiveness of Smecta in Combination With Oral Rehydration in the Treatment of Acute Watery Diarrhoea in Infants and Children

Launched by IPSEN · Jul 14, 2006

Trial Information

Current as of June 24, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • male
  • acute watery diarrhoea defined as at least 3 watery stools per 24 hours
  • duration of watery diarrhoea of less than 72 hours and with at least 1 watery stool for the last 12 hours
  • dehydration signs requiring oral rehydration according to current WHO guidelines
  • Exclusion Criteria:
  • severe dehydration that needs IV therapy
  • presence of gross blood in stools
  • fever \>39 degrees Celsius

About Ipsen

Ipsen is a global biopharmaceutical group dedicated to innovation and specialty care, focusing on the discovery, development, and commercialization of transformative medicines for patients with serious diseases. With a strong emphasis on oncology, neuroscience, and rare diseases, Ipsen leverages cutting-edge research and advanced technologies to deliver high-quality therapies that address unmet medical needs. Committed to scientific excellence and ethical practices, Ipsen collaborates with healthcare professionals and stakeholders to drive patient-centered solutions and improve health outcomes worldwide.

Locations

Kluang, Johor, Malaysia

Jalan Semenyih, Kajang, Malaysia

Jalan Mahang, Kedah, Malaysia

Hospital Sultan Haji Ahmad Shah, Pahang, Malaysia

Seri Manjung, Perak, Malaysia

Teluk Intan, Perak, Malaysia

Alor Setar Kedah, , Malaysia

Ipoh Perak, , Malaysia

Kelantan, , Malaysia

Kuala Terengganu, , Malaysia

Kuantan Pahang, , Malaysia

Kuching, , Malaysia

Melaka, , Malaysia

Negeri Sembilan, , Malaysia

Pulau Pinang, , Malaysia

Selangor, , Malaysia

Selangor, , Malaysia

Sungai Petani, , Malaysia

Taiping Perak, , Malaysia

Patients applied

0 patients applied

Trial Officials

Ipsen Medical Director

Study Director

Ipsen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials